Publicacións en colaboración con investigadores/as de Universidad Europea de Madrid (49)

2024

  1. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

    Journal of Clinical Medicine, Vol. 13, Núm. 9

  2. Peripartum Takotsubo Cardiomyopathy: A Review and Insights from a National Registry

    Journal of Cardiovascular Development and Disease, Vol. 11, Núm. 2

  3. Prevalence and prognosis of anxiety, insomnia, and type D personality in patients with myocardial infarction: A Spanish cohort

    Cardiology journal, Vol. 31, Núm. 2, pp. 261-270

  4. Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 304-313

  5. Prognostic Utility of Society for Cardiovascular Angiography and Interventions Shock Stage Approach for Classifying Cardiogenic Shock Severity in Takotsubo Syndrome

    Journal of the American Heart Association, Vol. 13, Núm. 6, pp. e032951

  6. Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohort

    International Journal of Cardiology, Vol. 405

  7. Repetitive ambulatory levosimendan as a bridge to heart transplantation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Cardiovascular disease in women: Do we need new diagnostic and therapeutic strategies?

    Kardiologia polska, Vol. 81, Núm. 4, pp. 338-349

  3. Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis

    European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 8, pp. 1120-1128

  4. Conduction system pacing and atrioventricular node ablation in heart failure: The PACE-FIB study design

    ESC Heart Failure, Vol. 10, Núm. 6, pp. 3700-3709

  5. Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  6. Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry

    ESC Heart Failure, Vol. 10, Núm. 5, pp. 2875-2881

  7. Heart rate disorders in patients with Tako-tsubo syndrome

    Medicina Clinica, Vol. 161, Núm. 8, pp. 330-337

  8. Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  9. Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction

    Clinical Research in Cardiology

  10. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

    Revista Espanola de Cardiologia, Vol. 76, Núm. 3, pp. 183-196

  11. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

    Radiologia, Vol. 65, Núm. 3, pp. 269-284

  12. Optical coherence tomography assessment of pulmonary vascular remodeling in advanced heart failure. The OCTOPUS-CHF study

    Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 312-321

  13. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)

    Journal of Clinical Medicine, Vol. 12, Núm. 2